A Paris biotech building digital twins of cells from multi-omics data, using AI to find molecular targets that push diseased cells toward health.
DeepLife
Released January 29, 2026
Large causal cell model trained on cancer perturbation data that generalizes zero-shot to patient-derived cells for therapeutic target prioritization.